Latest News in the pharma Industry

Biopharma News

Hospira Statement on FDA Approval of the First Biosimilar in the US

Hospira Statement on FDA Approval of the First Biosimilar in the US

6 Mar 2015

Read more 
JSR Corp. and KBI Biopharma Agree to Acquisition; INCJ and CMIC of Japan also Participate

JSR Corp. and KBI Biopharma Agree to Acquisition; INCJ and CMIC of Japan also Participate

5 Mar 2015

Read more 
FDA Accepts sBLA for Yervoy as Adjuvant Treatment for Patients with Stage 3 Melanoma

FDA Accepts sBLA for Yervoy as Adjuvant Treatment for Patients with Stage 3 Melanoma

3 Mar 2015

Read more 
Study of Next-Generation Investigational HIV-1 Maturation Inhibitor Shows Positive Results

Study of Next-Generation Investigational HIV-1 Maturation Inhibitor Shows Positive Results

2 Mar 2015

Read more 
Cobra Biologics and The University of Manchester Receive £217K Innovate UK/BBSRC Funding to Streamline the Production of Biologics

Cobra Biologics and The University of Manchester Receive £217K Innovate UK/BBSRC Funding to Streamline the Production of Biologics

24 Feb 2015

Read more 
Particle Sciences to Chair Session and Present on its SATx Technology at the 249th ACS National Meeting

Particle Sciences to Chair Session and Present on its SATx Technology at the 249th ACS National Meeting

24 Feb 2015

Read more 
Sosei Acquires Heptares Therapeutics for up to USD 400 Million

Sosei Acquires Heptares Therapeutics for up to USD 400 Million

23 Feb 2015

Read more 
Inflectra Patient Registry Reports Interim Results in the Treatment of Inflammatory Bowel Disease

Inflectra Patient Registry Reports Interim Results in the Treatment of Inflammatory Bowel Disease

20 Feb 2015

Read more 
Consortium to Receive Funding to Develop Enhanced Biomanufacturing Platforms

Consortium to Receive Funding to Develop Enhanced Biomanufacturing Platforms

18 Feb 2015

Read more 
Hospira Launches First Biosimilar Monoclonal Antibody Inflectra  in Major European Markets

Hospira Launches First Biosimilar Monoclonal Antibody Inflectra in Major European Markets

16 Feb 2015

Read more 
Aileron Therapeutics Initiates Phase I Cancer Study of ALRN-6924 in Advanced Hematologic and Solid Malignancies with Wild Type p53

Aileron Therapeutics Initiates Phase I Cancer Study of ALRN-6924 in Advanced Hematologic and Solid Malignancies with Wild Type p53

13 Feb 2015

Read more 
GSK Strengthens Early-Stage Vaccine Pipeline with Acquisition of GlycoVaxyn AG

GSK Strengthens Early-Stage Vaccine Pipeline with Acquisition of GlycoVaxyn AG

12 Feb 2015

Read more